Jim Cramer's Stop Trading: InterMune Is for Real

NEW YORK (TheStreet) -- InterMune (ITMN) "had an amazing move" and is now stabilizing, according to TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio.

Speaking during CNBC's "Cramer's Stop Trading" segment, he said there is a "very good analyst" at R.W. Baird named Brian Skorney who is "writing very positive things."

He added that investors were initially very optimistic on the prospects of the company's pulmonary fibrosis treatment. 

Phase III results are due out soon and Cramer suggested that "there is going to be fireworks" if the company has positive news about the drug to announce at the American Thoracic Society's annual meeting. 

Although biotech stocks have been out of favor among investors, "I think InterMune is for real," Cramer concluded.

-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

2 More Reasons to Sell All Your Stocks and Run Away

2 More Reasons to Sell All Your Stocks and Run Away

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast